These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14740969)

  • 1. How to use statins in patients with chronic liver disease.
    Russo MW; Jacobson IM
    Cleve Clin J Med; 2004 Jan; 71(1):58-62. PubMed ID: 14740969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Side effects of statins: hepatitis versus "transaminitis"-myositis versus "CPKitis".
    Dujovne CA
    Am J Cardiol; 2002 Jun; 89(12):1411-3. PubMed ID: 12062737
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety of statins: effects on muscle and the liver.
    Vasudevan AR; Hamirani YS; Jones PH
    Cleve Clin J Med; 2005 Nov; 72(11):990-3, 996-1001. PubMed ID: 16315438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription of statins to dyslipidemic patients affected by liver diseases: a subtle balance between risks and benefits.
    Anfossi G; Massucco P; Bonomo K; Trovati M
    Nutr Metab Cardiovasc Dis; 2004 Aug; 14(4):215-24. PubMed ID: 15553600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Enzyme diagnosis and liver diseases].
    Schmidt E; Schmidt FW
    Schweiz Med Wochenschr; 1969 Apr; 99(15):514-21. PubMed ID: 5784493
    [No Abstract]   [Full Text] [Related]  

  • 6. The SGOT/SGPT ratio in alcoholic liver disease.
    Alves PS; Camilo EA; Correia JP
    Acta Med Port; 1981; 3(4):255-60. PubMed ID: 7331882
    [No Abstract]   [Full Text] [Related]  

  • 7. Can "statins" be used in patients with hepatitis B?
    Safeer RS
    Postgrad Med; 2002 May; 111(5):119-20. PubMed ID: 12040858
    [No Abstract]   [Full Text] [Related]  

  • 8. Change in ALT levels after administration of HMG-CoA reductase inhibitors to subjects with pretreatment levels three times the upper normal limit in clinical practice.
    Kim H; Lee H; Kim TM; Yang SJ; Baik SY; Lee SH; Cho JH; Lee H; Yim HW; Choi IY; Yoon KH; Kim HS
    Cardiovasc Ther; 2018 Jun; 36(3):e12324. PubMed ID: 29464863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum adenosine deaminase in acute viral hepatitis and chronic liver diseases].
    Nilius R; Zipprich B
    Z Gesamte Inn Med; 1973 Feb; 28(4):101-5. PubMed ID: 4701002
    [No Abstract]   [Full Text] [Related]  

  • 10. [Activity interrelation of serum GOT and GPT transaminases in chronic liver diseases and their significance in liver cirrhosis].
    Busch D; Fernbacher K
    Verh Dtsch Ges Inn Med; 1969; 75():347-50. PubMed ID: 5400148
    [No Abstract]   [Full Text] [Related]  

  • 11. [Behavior of some mitochondrial enzymes in the blood of patients with various liver diseases].
    De Franchis R; Tornaghi G; Bellobuono A; Bitto T; Mirabile E; Del Ninno E; Ideo G
    Quad Sclavo Diagn; 1972 Mar; 8(1):262-70. PubMed ID: 4663755
    [No Abstract]   [Full Text] [Related]  

  • 12. [Plasma enzyme activities in liver diseases during standardized physical exertion].
    Linneke P; Hoffmann H; Ehrke D; Lazarus P
    Z Gesamte Inn Med; 1973 Jan; 28(1):11-4. PubMed ID: 4694329
    [No Abstract]   [Full Text] [Related]  

  • 13. Statins and the liver.
    Dassanayake AS; de Silva HJ
    Ceylon Med J; 2010 Jun; 55(2):37-9. PubMed ID: 20645541
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiretroviral drugs and liver injury.
    Soriano V; Puoti M; Garcia-Gascó P; Rockstroh JK; Benhamou Y; Barreiro P; McGovern B
    AIDS; 2008 Jan; 22(1):1-13. PubMed ID: 18090386
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serum transaminases and mental manifestations in alcoholic liver disease].
    Olivieri G; Tinelli G; Mancuso CE
    Fracastoro; 1971; 64(3):176-8. PubMed ID: 5143151
    [No Abstract]   [Full Text] [Related]  

  • 16. A nitrofurantoin-induced disorder simulating chronic active hepatitis. A case report.
    Fagrell B; Strandberg I; Wengle B
    Acta Med Scand; 1976; 199(3):237-9. PubMed ID: 1258704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Behavior of gamma glutamyl transpeptidase in hepatobiliary diseases].
    Kresbach E; Thurnher H
    Wien Med Wochenschr; 1973 Apr; 123(16):253-8. PubMed ID: 4144931
    [No Abstract]   [Full Text] [Related]  

  • 18. [Should we do a liver puncture biopsy in patients with chronic "unexplained" cytolyses?].
    De Lédinghen V
    Gastroenterol Clin Biol; 2002; 26(8-9):724-7. PubMed ID: 12434076
    [No Abstract]   [Full Text] [Related]  

  • 19. Liver injury after contrast-enhanced, computed tomography with iopromide.
    Re G; Lanzarini C; Melandri R
    J Toxicol Clin Toxicol; 1998; 36(3):261-2. PubMed ID: 9656987
    [No Abstract]   [Full Text] [Related]  

  • 20. [Determination of serum guanase activity in diseases of liver parenchyma].
    Kramp B; Teichmann W; Rehpenning W
    Dtsch Z Verdau Stoffwechselkr; 1973; 33(1):11-5. PubMed ID: 4773207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.